Home

Hans van Houte, CFO: Nurix Therapeutics NRIX Sell · Filed 24/05/02

Trade details

Type
Insider sale
Amount
$44,892.17
Shares · price
3,499 sh · $12.83 a share
Held after
68,333 sh
Trade date
24/05/02
Filed
24/05/02
Days to filing
0 days

Sold 4.9% of holdings

Share of holding sold
4.9%

Nurix Therapeutics trades, last 26 weeks

What else happened in Nurix Therapeutics around then

Filed or reported within 30 days of the trade day · 24/04/02~24/06/01

Hans van Houte's recent trades

  • Hans van Houte

    Planned sale10b5-1 planNurix Therapeutics

    $110.6K

    Filed 08/04

  • Hans van Houte

    Sell10b5-1 planNurix Therapeutics

    $223.4K

    Filed 05/05

  • Hans van Houte

    Sell10b5-1 planNurix Therapeutics

    $9,999

    Filed 05/05

  • Hans van Houte

    Planned sale10b5-1 planNurix Therapeutics

    $238K

    Filed 05/05

  • Hans van Houte

    SellNurix Therapeutics

    $39.8K

    Filed 04/30